“…TMS is continuously establishing itself as one of the “tools of the trade” in psychiatric therapeutic practice (Kammer and Spitzer, 2012) improving mental functions in: Parkinson's disease (Pascual-Leone et al, 1994), aphasia (Medina et al, 2012), motor control after stroke (Takeuchi et al, 2005), epilepsy (Nitsche and Paulus, 2009), depression (Lisanby et al, 2009; Conforto et al, 2014), schizophrenia (Levkovitz et al, 2011; Kammer and Spitzer, 2012), autism (Krause et al, 2012), chronic migraine (Conforto et al, 2014), dyslexia (Costanzo et al, 2013), neglect (Fasotti and Van Kessel, 2013), obsessive-compulsive disorder (OCD) (Mantovani et al, 2013), chronic pain (Moreno-Duarte et al, 2014), and social anxiety disorder (Paes et al, 2013). The TMS therapy applied to younger patients (children and adolescents) improves cognitive functions (Vicario and Nitsche, 2013) in: stroke affecting the motor cortex (Kirton et al, 2008), epilepsy (Fregni et al, 2005), ADHD (Weaver et al, 2012), Tourette syndrome (Le et al, 2013), autism (Baruth et al, 2010), treatment-resistant depression (Bloch et al, 2008), and medication-resistant schizophrenia (Jardri et al, 2012). …”